Blood is a weekly medical journal published by the American Society of Hematology. It was founded by Dr. William Dameshek, the researcher credited with describing the concept of myeloproliferative diseases and participating in the first studies of nitrogen mustard in various blood malignancies, in 1946, and has since been in continuous publication.With 1,364 articles published annually, an impact factor of 10.555, and an Immediacy Index of 2.209, Blood is the most cited peer-reviewed publication in the field. It provides an international forum for the publication of original articles describing basic laboratory, translational, and clinical investigations in hematology. The journal covers all aspects of hematology, including disorders of leukocytes, both benign and malignant, erythrocytes, platelets, hemostatic mechanisms, vascular biology, immunology, and hematologic oncology. All articles undergo a rigorous peer review and are selected on the basis of the originality of the findings, the superior quality of the work described, and the clarity of presentation. Blood is indexed and abstracted by Index Medicus, Excerpta Medica, Current Contents/Life Sciences, Current Contents/Clinical Medicine, Science Citation Index, SCISEARCH, Automatic Subject Citation Alert, ISI/BIOMED, and BIOSIS.
Blood Cancer Journal is a peer-reviewed, online, open access, sister journal to the well-established and highly respected, Leukemia (2011 impact factor 9.561, Journal Citation Reports, Thomson Reuters, 2011), bringing to the fore outstanding pre-clinical and clinical research in the field of hematology, with ramifications into translational biology research down to new therapies. Topics of particular concentration will include, but are not limited to, the following:
Blood Cells, Molecules & Diseases emphasizes not only blood cells, but also covers the molecular basis of hematologic disease and studies of the diseases themselves. This is an invaluable resource to all those interested in the study of hematology, cell biology, immunology, and human genetics.Research Areas include:• Hematolymphopoiesis• Genetics of Blood Cells and Proteins• Molecular Biology of Blood Cells and Proteins• Pathophysiology of Blood Cells and Proteins• Hematological Malignancies• Disorders of Blood Cells and Coagulation ProteinsNote to Authors - please use the "Submit your paper" button on the right when submittingBenefits to authorsWe also provide many author benefits, such as free PDFs, a liberal copyright policy, special discounts on Elsevier publications and much more. Please click here for more information on our author services .Please see our Guide for Authors for information on article submission. If you require any further information or help, please visit our support pages: http://support.elsevier.com
This journal is an international fully refereed journal that features review and original research articles on all clinical, laboratory, and experimental aspects of haemostasis and thrombosis. The journal is devoted to publishing significant developments worldwide in the field of blood coagulation, fibrinolysis, thrombosis, platelets and the kininogen-kinin system, as well as dealing with those aspects of blood rheology relevant to haemostasis and the effects of drugs on the haemostatic components.Blood Coagulation and Fibrinolysis publishes mutation reports detailing the mutated gene and giving a brief clinical history of the propositus. The journal also publishes correspondence and technical reports. The emphasis is on speed of publication. American Heart Association members are eligible for a discount on subscription rates.Website: www.bloodcoagulation.com.
For outstanding coverage of the latest advances in hypertension research, turn to Blood Pressure, a primary source for authoritative and timely information on all aspects of hypertension research and management.
Features include:
• Physiology and pathophysiology of blood pressure regulation
• Primary and secondary hypertension
• Cerebrovascular and cardiovascular complications of hypertension
• Detection, treatment and follow-up of hypertension
• Non pharmacological and pharmacological management
• Large outcome trials in hypertension
Blood Pressure is endorsed by the European Society of Hypertension (ESH).
Blood Pressure is open for submission of the following types of articles: Original Research Articles, Review Articles, Letters to the Editor and Case Reports. Editorials are in most cases written by the Editors or otherwise by invitation only. However, traditionally a special feature has been Personal Views, in which distinguished scientists present thoughts, views, debates and reviews that address important topics of great current interest; these may be submitted as Review Article with “Personal View” clearly marked as subtitle and in the cover letter. Blood Pressure has also published announcements of important hypertension meetings and occasionally short reports from Hypertension Societies world-wide; these may be submitted as Letters to the Editor. Other articles requiring extensive space, such as monographs, doctoral theses and congress transactions, may be published as supplements.
Blood Pressure Monitoring contains papers dealing with all aspects of manual, automated and ambulatory monitoring with an emphasis on clinical medicine. It is devoted to original research covering blood pressure measurement and blood pressure variability.Sections are dedicated to: evaluation of blood pressure and heart rate measurement devices; analytic methodology of blood pressure over time and its variability; clinical pharmacology and therapeutics; clinical practice and epidemiology; and health policy and economics.Website: www.bpmonitoring.com.
Practical information on hemodialysis, hemofiltration, peritoneal dialysis, and apheresis is featured in this journal. Recognizing the critical importance of equipment and procedures, particular emphasis has been placed on reports, drawn from a wide range of fields, describing technical advances and improvements in methodology. Papers reflect the search for cost-effective solutions which increase not only patient survival, but also patient comfort and disease improvement by prevention or correction of undesirable effects. Advances in vascular access and blood anticoagulation, problems associated with exposure of blood to foreign surfaces, and acute-care nephrology, including continuous therapies, also receive attention. Nephrologists, internists, intensivists, and hospital staff involved in dialysis, apheresis, and immunoadsorption for acute and chronic solid organ failure will find this journal useful and informative. Blood Purification also serves as a platform for multidisciplinary experiences involving nephrologists, cardiologists, and critical care physicians in order to expand the level of interaction between different disciplines and specialties.
This respected international journal, Blood Reviews, is a vital information resource, bringing together appraisals of clinical practice, and research from recognized experts. Specially commissioned articles from leading researchers and practitioners guarantee truly global coverage of all the sub-specialties of hematology.Blood Reviews publishes review articles covering the spectrum of clinical and laboratory haematological practice and research. Although most reviews are invited, the editors welcome suggestions from potential authors. They should first write a brief outline of an intended review and send this to Dr Trevor Baglin (trevor.baglin@addenbrookes.nhs.uk) or to Dr Hillard Lazarus (hml@case.edu).Benefits to authorsWe also provide many author benefits, such as free PDFs, a liberal copyright policy, special discounts on Elsevier publications and much more. Please click here for more information on our author services.Please see our Guide for Authors for information on article submission. If you require any further information or help, please visit our support pages: http://support.elsevier.com